Literature DB >> 11858188

D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.

Astrid C M Andreescu1, Mary Cushman, Frits R Rosendaal.   

Abstract

We studied the association of D-dimer with the risk of deep vein thrombosis (DVT). D-dimer was measured in 474 patients more than 6 months after diagnosis of a first DVT and in 474 age- and sex-matched controls. For D-dimer above the 70th percentile (130.5 ng/ml), the odds ratio (OR) for DVT was 2.2 (95% CI, 1.6-2.9). The association was unchanged with adjustment for other risk factors. Excluding participants with Factor V Leiden, prothrombin 20210A, or factors VIIIc or IX above the 90th percentile, the OR was 1.6 (95% CI, 1.1-2.3). The risks of DVT with the joint presence of high D-dimer and either factor V Leiden or prothrombin 20210A were increased 12.4-fold (95% CI 5.6-27.7) and 7.2-fold (95% CI 2.1-25.1), respectively. Higher D-dimer concentration was associated with the risk of DVT, and was supra-additive to the risks associated with factor V Leiden and the prothrombin 20210A variant. Persistence of this association in the absence of other hemostatic risk factors for DVT suggests that high D-dimer may be related to other, as yet unknown, risk factors for venous thrombosis. Confirmation of these findings is desirable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858188

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Neil A Zakai; Pamela L Lutsey; Aaron R Folsom; Susan R Heckbert; Mary Cushman
Journal:  Thromb Haemost       Date:  2010-04-29       Impact factor: 5.249

2.  Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study.

Authors:  Dinah Konnerth; Florian Schwarz; Michael Probst; Martin Seidler; Tanja Wagner; Christian Faul; Wolfgang von Scheidt; Martin Schwaiblmair; Thomas M Berghaus
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 3.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

4.  Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.

Authors:  M Cushman; P W Callas; J O Denenberg; E G Bovill; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

5.  Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Alvaro Alonso; Kristen M George; Nicholas S Roetker; Weihong Tang; Mary Cushman
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

6.  Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.

Authors:  P L Lutsey; A R Folsom; S R Heckbert; M Cushman
Journal:  J Thromb Haemost       Date:  2009-07-28       Impact factor: 5.824

7.  High Plasma Levels of D-Dimer Are Independently Associated with a Heightened Risk of Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage.

Authors:  Xuan Cheng; Lu Zhang; Nan-Chang Xie; Yun-Qing Ma; Ya-Jun Lian
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

8.  Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study.

Authors:  Jiří Masopust; Radovan Malý; Ctirad Andrýs; Martin Vališ; Jan Bažant; Ladislav Hosák
Journal:  BMC Psychiatry       Date:  2011-01-03       Impact factor: 3.630

9.  Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Line H Evensen; Aaron R Folsom; James S Pankow; John-Bjarne Hansen; Matthew A Allison; Mary Cushman; Pamela L Lutsey
Journal:  J Thromb Haemost       Date:  2021-05-07       Impact factor: 16.036

10.  Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.

Authors:  N B Adams; P L Lutsey; A R Folsom; D H Herrington; C T Sibley; N A Zakai; S Ades; G L Burke; M Cushman
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.